Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel inotropic agent shows more potency than ouabain

June 21, 2004

Vical provides program update

June 21, 2004

PSMA-targeting immunotherapies presented at ASCO

June 21, 2004

Neurogen provides update on portfolio of clinical and preclinical programs

June 21, 2004

Data on the pharmacokinetics of ramelteon presented at sleep conference

June 21, 2004

Improved prevention of CINV found with a palonosetron combination therapy

June 21, 2004

Antisense morpholino-oligomers inhibit coronavirus proliferation and growth

June 21, 2004

Savient updates recent developments

June 21, 2004

Non-antibacterial macrolides with potential as antiiflammatory agents

June 18, 2004

Novel IL-8 receptor antagonists and their use described by GSK

June 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...